Abstract
In the United States, nearly 5% of the population has or has had cancer. Anesthetists frequently encounter patients in all stages of cancer and cancer treatment. This chapter highlights the short term and long term end-organ effects of common chemotherapeutics relevant to the anesthetist and reviews current concepts about how anesthetics may impact cancer and cancer survival.
| Original language | English (US) |
|---|---|
| Title of host publication | Pharmacology and Physiology for Anesthesia |
| Subtitle of host publication | Foundations and Clinical Application |
| Publisher | Elsevier |
| Pages | 753-768 |
| Number of pages | 16 |
| ISBN (Electronic) | 9780323481106 |
| ISBN (Print) | 9780323776981 |
| DOIs | |
| State | Published - Jan 1 2018 |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Inc. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Angiogenesis
- Cardiotoxicity
- Immunotherapy
- Malignancy
- Metastasis
- Monoclonal antibodies
- Oxygen free radicals
- Pulmonary fibrosis
Fingerprint
Dive into the research topics of 'Chemotherapy, immunosuppression, and anesthesia'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS